SGMOQOTCBiological Products, (No Diagnostic Substances)

Sangamo Therapeutics, Inc (SGMOQ) earnings date, market-implied expected move, and options open interest by expiry

Price unavailable.

Volume540,806Mkt cap$48.1M

SGMOQ

Sangamo Therapeutics, Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 6

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

−0.37%

shaded = implied · ▲▼ = realized

May 14 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

—

Top fund weight

—

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Sangamo Therapeutics (SGMOQ) is expected to report on Nov 6 before open (estimated date).

Implied vs realized

8 reports

—≥ implied

Aug 6 '24Aug 6 '24confirmed—▼−13.46%—

Nov 12 '24Nov 12 '24confirmed—▼−9.96%—

Mar 17 '25Mar 17 '25confirmed—▼−16.23%—

Aug 7 '25Aug 7 '25confirmed—▼−5.33%—

Q3 FY25Nov 6 '25confirmed—▼−16.29%—

Q4 FY25Feb 3 '26confirmed—▼−31.33%—

Q1 FY26Mar 30 '26confirmed—▼−19.66%—

May 14 '26May 14 '26confirmed—▼−0.37%—

quarterimplied−35%0+35%realized×

May '26—▼−0.37%—

Q1 FY26—▼−19.66%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Oct 20 close

0.02OI · 2 expiries · Oct 20 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

60%Nov 2019d3310%

9,4190%Jan 1575d0.2636,5880%0.26

ExpiryPutsCallsP/C

Nov 2019d60%3310%0.02

Jan 1575d9,4190%36,5880%0.26

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

as filedQ1 FY26

−2149.45%as filednet margin · revenue −89.87% QoQ · −77.60% YoY

Revenue$1M−89.87%

Gross profit$1M100.00%−89.87%

Operating income−$32M−2215.40%+16.38%

Pre-tax income−$31M+18.37%

Net income−$31M−2149.45%+17.17%

Cost of revenue$0—

Operating expenses$33M−36.32%

Tax$0+100.00%

Other income$951,000+311.69%

Source: SEC filings · standardized · QE Mar 31 '26 · bars = % of revenue

Revenue flow

Intraday

No trades yet today.

Intraday

Event sensitivity

NFP ×0.92· ±5.5% vs ±5.9% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±5.5%8 of 10×0.92

FOMCrate decision±5.3%12 of 24×0.90

GDPgross domestic product±4.9%13 of 20×0.83

CPROFcorporate profits±4.8%9 of 12×0.80

PCEpersonal income & outlays±4.4%11 of 20×0.75

PPIproducer prices±4.1%5 of 11×0.69

CPIconsumer prices±3.4%4 of 11×0.57

Bar = avg |move| to ±6% · tick = ±5.9% avg day · ×base = |move| ÷ ±5.9% · min 6 releases

Earnings history

EPS -0.08 · consensus —

Quarter	Reported	EPS	Consensus
Q1 FY26	Mar 30 '26 · confirmed	-0.08	—
Q4 FY25	Feb 3 '26 · confirmed	-0.11	—
Q3 FY25	Nov 6 '25 · confirmed	-0.11	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod